Difference between revisions of "Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5 (Q9823)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: First Author string (P149): Oberneder R, #quickstatements; #temporary_batch_1589996169159)
(‎Created claim: Page(s) (P105): 2530-2538, #quickstatements; #temporary_batch_1590074839150)
 
(6 intermediate revisions by the same user not shown)
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1016/j.ejca.2006.05.029 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 16930989 / rank
 +
Normal rank
Property / Publication Date
 +
2006
Timestamp+2006-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2006 / rank
 +
Normal rank
Property / Published In Name String
 +
Eur. J. Cancer
Property / Published In Name String: Eur. J. Cancer / rank
 +
Normal rank
Property / Volume
 +
42
Property / Volume: 42 / rank
 +
Normal rank
Property / title
 +
A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English)
Property / title: A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English) / rank
 +
Normal rank
Property / Page(s)
 +
2530-2538
Property / Page(s): 2530-2538 / rank
 +
Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Oberneder R
    0 references
    0 references
    2006
    0 references
    Eur. J. Cancer
    0 references
    42
    0 references
    A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English)
    0 references
    2530-2538
    0 references